PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Active Pharmacist Ward Integration Outperforms Education in Renal Prescribing

clinical pharmacistdrug-related problemsrenal dysfunctionchronic kidney diseaseacute kidney injurymedication safetyPCNE classificationrenal dose adjustmentquasi-experimentalpolypharmacy Medication Safety
Also in Nephrology

Background Information

Pharmacist interventions cut drug-related issues by 30% in renal patients.

Renal dysfunction complicates medication management, increasing the risk of drug-related problems (DRPs). Pharmacist interventions reduced DRPs by 30%, ensuring safer medication use in patients with renal dysfunction. The study supports integrating pharmacists in care teams to improve medication safety in patients with renal impairment. Clinical pharmacists significantly decrease drug-related problems in hospitalized patients with renal dysfunction.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Özmen Ö, Bektay MY, Karatoprak C, İzzettin FV

Citation: Özmen Ö, Bektay MY, Karatoprak C, et al. Impact of clinical pharmacist interventions on drug-related problems in hospitalised patients with renal dysfunction: a quasi-experimental study. Scientific reports. 2026;16(1). doi:10.1038/s41598-026-51690-w

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.